Literature DB >> 8896394

Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population.

Q L Hao1, F T Thiemann, D Petersen, E M Smogorzewska, G M Crooks.   

Abstract

Long-term culture-initiating cells (LTC-IC) are hematopoietic progenitors able to generate colony-forming unit-cells (CFU) after 5 to 8 weeks (35 to 60 days) of culture on bone marrow (BM) stroma and represent the most primitive progenitors currently detectable in vitro. We have recently reported that long-term cultures initiated with CD34+CD38- cells from BM or cord blood are able to continue generating CFU for at least 100 days, ie, beyond the standard LTC-IC period. In this report, single-cell cultures from cord blood and retroviral marking of cord blood and BM were used to study whether the subpopulation of CD34+CD38- cells able to generate CFU beyond 60 days ("extended long-term culture-initiating cells" or ELTC-IC) are functionally distinct from LTC-IC in terms of timing of initial clonal proliferation and generative capacity. All cord blood LTC-IC formed clones of greater than 50 cells by day 30. In contrast, cord blood ELTC-IC proliferated later in culture, 50% forming clones after day 30. Although efficient retroviral marking of LTC-IC was seen (25% to 45%), marking of ELTC-IC was inefficient (< 1%), consistent with a more quiescent progenitor population. There was a positive correlation between time of clonal proliferation and generative capacity. ELTC-IC generated threefold to fourfold more progeny than did LTC-IC (P < .002). These studies show that there is a functional hierarchy of progenitors in long-term culture which correlates with their level of quiescence. By extending the LTC-IC assay, a more primitive progenitor may be studied that may be functionally closer to the human long-term repopulation stem cell in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896394

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

Authors:  S S Case; M A Price; C T Jordan; X J Yu; L Wang; G Bauer; D L Haas; D Xu; R Stripecke; L Naldini; D B Kohn; G M Crooks
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

Authors:  E Conneally; J Cashman; A Petzer; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Maintenance and expansion of hematopoietic stem/progenitor cells in biomimetic osteoblast niche.

Authors:  Jing Tan; Ting Liu; Li Hou; Wentong Meng; Yuchun Wang; Wei Zhi; Li Deng
Journal:  Cytotechnology       Date:  2010-09-10       Impact factor: 2.058

Review 4.  Hematopoietic stem cell: self-renewal versus differentiation.

Authors:  Jun Seita; Irving L Weissman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

5.  Optimized transduction of canine paediatric CD34(+) cells using an MSCV-based bicistronic vector.

Authors:  S E Suter; T A Gouthro; P A McSweeney; R A Nash; M E Haskins; P J Felsburg; P S Henthorn
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

6.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

7.  New relationships of human hematopoietic lineages facilitate detection of multipotent hematopoietic stem and progenitor cells.

Authors:  André Görgens; Stefan Radtke; Peter A Horn; Bernd Giebel
Journal:  Cell Cycle       Date:  2013-10-23       Impact factor: 4.534

8.  Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.

Authors:  Kismet Baldwin; Fabrizia Urbinati; Zulema Romero; Beatriz Campo-Fernandez; Michael L Kaufman; Aaron R Cooper; Katelyn Masiuk; Roger P Hollis; Donald B Kohn
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

9.  The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.

Authors:  Dennis L Haas; Carolyn Lutzko; Aaron C Logan; Gerald J Cho; Dianne Skelton; Xiao Jin Yu; Karen A Pepper; Donald B Kohn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 10.  Contribution of human hematopoietic stem cells to liver repair.

Authors:  Ping Zhou; Louisa Wirthlin; Jeannine McGee; Geralyn Annett; Jan Nolta
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.